In this study, we found that rhCNB treatment resulted in a substantial decrease in expression of Bcl-2 and Bcl-xL in hepatoma cells, while no obvious reduction in normal liver cells (Supplementary Figure 4B). This evidence concerns the gene BCL2L1 and hepatocellular carcinoma.